[Late damage after Rh-erythroblastosis, ABO-erythroblastosis and hyperbilirubinemia in the neonate (author's transl)].
D000017:ABO Blood-Group System; D001264:Athetosis / Q000209:etiology; D001787:Blood Group Incompatibility / Q000150:complications; D002547:Cerebral Palsy / Q000209:etiology; D002648:Child; D002653:Child Behavior Disorders / Q000209:etiology; D002675:Child, Preschool; D003744:Dental Enamel Hypoplasia / Q000209:etiology; D004899:Erythroblastosis, Fetal / Q000150:complications*; D005260:Female; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000209:etiology; D007360:Intelligence; D007567:Jaundice, Neonatal / Q000150:complications*; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D013064:Speech Disorders / Q000209:etiology; D013285:Strabismus / Q000209:etiology; D013997:Time Factors; D014075:Tooth Discoloration / Q000209:etiology; D014786:Vision Disorders / Q000209:etiology
D000017:ABO Blood-Group System; D012204:Rh-Hr Blood-Group System
Bleibende Schäden nach Rh-Erythroblastose, ABO-Erythroblastose und Hyperbilirubinämie in der Neugeborenenperiode.